Grant ID RP110395
Awarded On October 29, 2010
Title A genetic approach to target EWS-FLI1 oncoprotein in Ewing's Sarcoma
Program Academic Research
Award Mechanism High Impact/High Risk
Institution/Organization The University of Texas Southwestern Medical Center
Principal Investigator/Program Director James F Amatruda
Cancer Sites Bone, Childhood and Adolescent, Sarcoma
Contracted Amount $197,565
Lay Summary

Ewing’s sarcoma is a malignant tumor that occurs in children and young adults. Many cases are incurable, and even patients who are cured by combined surgery, chemotherapy and radiation face lifelong medical problems as a result of the treatment. We are seeking new approaches to find treatments that would be more effective and less toxic. Ewing’s sarcoma is caused by the presence of an abnormal protein, called EWS-FLI1, in the tumor cells. No one has figured out how to “shut off” EWS-FLI1 in the cancer cells, or even what in what type of cell in the body Ewing’s Sarcoma actually starts. We will use the zebrafish, a small aquarium fish that has cancer biology very similar to humans, to ta...

Read More